| 000 | 01431 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514165557.0 | ||
| 264 | 0 | _c20040408 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1175-3277 | ||
| 024 | 7 |
_a10.2165/00129784-200101060-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChew, D P | |
| 245 | 0 | 0 |
_aOral glycoprotein IIb/IIIa inhibitors: why don't they work? _h[electronic resource] |
| 260 |
_bAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _c2001 |
||
| 300 |
_a421-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xprevention & control |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xprevention & control |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aBhatt, D L | |
| 700 | 1 | _aTopol, E J | |
| 773 | 0 |
_tAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _gvol. 1 _gno. 6 _gp. 421-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00129784-200101060-00002 _zAvailable from publisher's website |
| 999 |
_c14454454 _d14454454 |
||